Intaset Pharmaceuticals Private Limited
About Intaset Pharmaceuticals Private Limited
Data last updated:
Intaset Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 28 April 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U21002KA2023PTC172974. Its GSTIN is 29AAHCI1028G1ZP (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Satish Thadaka (Managing Director) and Sreedhar Babu Gujjari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹35.84 Lakh. For the same year it recorded a net profit of ₹32,220 (net margin 0.9%) and EBITDA of ₹1.42 Lakh (EBITDA margin 4%).
As per MCA filings, the company has open charges of ₹8.5 Lakh on record.
Company details
Contact details
Intaset Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo 4 G No 1st Street, Laksman Mudliar Street, Bangalore, Karnataka, India – 560001
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Intaset Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Intaset Pharmaceuticals Private Limited, buy the company report.
Financials of Intaset Pharmaceuticals Private Limited
FY 2025 filings availableIntaset Pharmaceuticals Private Limited reported revenue of ₹35.84 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹1.42 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹32,220 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 4% |
| Net Profit Margin | 0.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Intaset Pharmaceuticals Private Limited, buy the company report.
Board of directors of Intaset Pharmaceuticals Private Limited
Intaset Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Thadaka | Managing Director | 28 Apr 2023 | 3 Years 5 Months | Current |
| Sreedhar Babu Gujjari Also directs: Sree Yashoram Broadcasting Private Limited | Director | 28 Apr 2023 | 3 Years 5 Months | Current |
Peer comparison
Intaset Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Norvik Pharmaceuticals Private Limited | ₹36.03 Lakh (FY 2020) | 15.0% | Bangalore, Karnataka, India | |||
| Somsa Pharmaceuticals Private Limited | ₹36.01 Lakh (FY 2020) | 339.0% | Sri Ganga Nagar, Rajasthan, India | |||
| Acecure Pharmaceuticals Private Limited | ₹35.94 Lakh (FY 2024) | 245.0% | Thane, Maharashtra, India | |||
| Intaset Pharmaceuticals Private Limitedthis company | ₹35.84 Lakh (FY 2024) | ₹32,220 | 0.9% | Bangalore, Karnataka, India | ||
| Caliber Pharmaceuticals Pvt Ltd | ₹35.78 Lakh (FY 2025) | -31.0% | Assam, India | |||
| Environ Pharmaceuticals Private Limited | ₹35.64 Lakh (FY 2019) | 29.0% | Thrissur, Kerala, India | |||
| Tuffail (India) Pharmaceuticals Private Limited | ₹35.61 Lakh (FY 2025) | -14.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Intaset Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2024 | 100968262 | State Bank of India | ₹8.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Intaset Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intaset Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Intaset Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCI1028G1ZP | Karnataka | Active | 03 Jun 2023 |
| 36AAHCI1028G1ZU | Telangana | Active | 06 Jun 2023 |
To see the full GST registrations and return filing status of Intaset Pharmaceuticals Private Limited, buy the company report.
Recent activity
Intaset Pharmaceuticals Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Ram Mohan Kodam ceased to be Director on 30 May 2024.
Frequently asked questions
Intaset Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in paper and paper products, within the paper industry. It was incorporated on 28 April 2023 (3+ years old) and is registered under CIN U21002KA2023PTC172974.
Intaset Pharmaceuticals has 2 current directors:
- Satish Thadaka - Managing Director
- Sreedhar Babu Gujjari - Director
The latest financial statements of Intaset Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Intaset Pharmaceuticals is 29AAHCI1028G1ZP, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAHCI1028G1ZU (Telangana).
The CIN (Corporate Identification Number) of Intaset Pharmaceuticals is U21002KA2023PTC172974. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intaset Pharmaceuticals was incorporated on 28 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Intaset Pharmaceuticals by revenue are Norvik Pharmaceuticals Private Limited, Somsa Pharmaceuticals Private Limited, Acecure Pharmaceuticals Private Limited, Caliber Pharmaceuticals Pvt Ltd, Environ Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ram Mohan Kodam ceased to be Director on 30 May 2024. Satish Thadaka was appointed as Managing Director on 28 Apr 2023. Sreedhar Babu Gujjari was appointed as Director on 28 Apr 2023.
The registered office of Intaset Pharmaceuticals is at No 4 G No 1st Street, Laksman Mudliar Street, Bangalore, Karnataka, India – 560001.
Intaset Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Intaset Pharmaceuticals has open charges of ₹8.5 Lakh and no satisfied charges on record as per latest MCA filings.